e-learning
resources
European Respiratory Review
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary capillary haemangiomatosis: a distinct entity?
Jason Weatherald, Peter Dorfmüller, Frédéric Perros, Maria-Rosa Ghigna, Barbara Girerd, Marc Humbert, David Montani
Source:
Eur Respir Rev, 29 (156) 190168; 10.1183/16000617.0168-2019
Journal Issue:
June
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jason Weatherald, Peter Dorfmüller, Frédéric Perros, Maria-Rosa Ghigna, Barbara Girerd, Marc Humbert, David Montani. Pulmonary capillary haemangiomatosis: a distinct entity?. Eur Respir Rev, 29 (156) 190168; 10.1183/16000617.0168-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Asbestosis
Whole genome sequencing of the highly virulent subtype B0/W148 of the Beijing genotype M.tuberculosis in Kharkiv, East Ukraine
Related content which might interest you:
Pulmonary embolism and COVID-19: a “special phenotype”?
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021
Combined pulmonary fibrosis and emphysema: A distinct entity?
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Pulmonary veno-occlusive disease and pulmonary capillary haemangiomatosis
Source: Eur Respir Mon 2012; 57: 182-193
Year: 2012
Pulmonary hypertension: a paradigm for rare pulmonary diseases
Source: Eur Respir Rev, 26 (146) 170120; 10.1183/16000617.0120-2017
Year: 2017
Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy?
Source: Eur Respir J 2010; 35: 223-224
Year: 2010
Lung involvement distinct from pulmonary hypertension: a new feature of POEMS syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002
Diffuse dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: A distinct entity or a variant of idiopathic pulmonary fibrosis?
Source: International Congress 2014 – ILDs 1
Year: 2014
A case of pulmonary capillary haemangiomatosis (PCH) diagnosed by lung biopsy
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Pulmonary embolism with a rare etiology: a case report
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006
Systemic vascularization in intralobar pulmonary sequestration - congenital or acquired?
Source: Eur Respir J 2001; 18: Suppl. 33, 492s
Year: 2001
Propanolol treatment in pulmonary capillary hemangiomatosis
Source: Annual Congress 2011 - Rare lung diseases in children
Year: 2011
Diffuse pulmonary development disorders- Molecular definable causes of pulmonary hypertension in the mature newborn
Source: International Congress 2015 – Neonatal and paediatric intensive care
Year: 2015
Secondary bronchogenic pulmonary hydatidosis: a rare entity
Source: Virtual Congress 2021 – Oncology, the mediastinum and infectious lung disease
Year: 2021
Lung fibrosis in Pulmonary Alveolar Proteinosis (PAP): different stages of a syndrome or distinct diseases?
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021
Multi nodular parenchymal pulmonary amyloidosis in primary Sjogren‘s syndrome: A case report
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
Smoking-related intersticial fibrosis (srif): A new entity?
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Pulmonary hypertension in orphan lung diseases
Source: Eur Respir Mon 2011; 54: 317-331
Year: 2011
Pulmonary hypertension and pulmonary vascular disease: course report
Source: Breathe, 14 (1) e4; 10.1183/20734735.019917
Year: 2018
Pulmonary embolism: still often underdiagnosed
Source: International Congress 2017 – State of the art session: "Interstitial lung disease and pulmonary vascular diseases"
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept